These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38158140)

  • 1. Genome-wide transcriptomic and biochemical profiling of major depressive disorder: Unravelling association with susceptibility, severity, and antidepressant response.
    Singh P; Srivastava A; Philip L; Ahuja SK; Shivangi ; Rawat C; Kutum R; Yadav J; Sood M; Chadda RK; Dash D; Vohora D; Kukreti R
    Genomics; 2024 Jan; 116(1):110772. PubMed ID: 38158140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentially expressed genes related to major depressive disorder and antidepressant response: genome-wide gene expression analysis.
    Woo HI; Lim SW; Myung W; Kim DK; Lee SY
    Exp Mol Med; 2018 Aug; 50(8):1-11. PubMed ID: 30076325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of circulating blood microRNA-374 and microRNA-10 levels in the pathogenesis and therapeutic mechanisms of major depressive disorder.
    Liu W; Zhang F; Zheng Y; He S; Zhang T; Guo Q; Xu H; Chen H; Liu C; Yu S; Jiang K; Li H; Li G; Wang X; Liu X
    Neurosci Lett; 2021 Oct; 763():136184. PubMed ID: 34418506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant Expression of Intracellular let-7e, miR-146a, and miR-155 Correlates with Severity of Depression in Patients with Major Depressive Disorder and Is Ameliorated after Antidepressant Treatment.
    Hung YY; Wu MK; Tsai MC; Huang YL; Kang HY
    Cells; 2019 Jun; 8(7):. PubMed ID: 31252530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A genome-wide association study of escitalopram treatment outcomes in patients with major depressive disorder.
    Ren S; Peng H; Zhang J; Yang J; He Y; Sun Z; Wang G
    Gene; 2024 Oct; 926():148596. PubMed ID: 38782219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide profiling of DNA methylome and transcriptome in peripheral blood monocytes for major depression: A Monozygotic Discordant Twin Study.
    Zhu Y; Strachan E; Fowler E; Bacus T; Roy-Byrne P; Zhao J
    Transl Psychiatry; 2019 Sep; 9(1):215. PubMed ID: 31477685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk.
    Srivastava A; Singh P; Gupta H; Kaur H; Kanojia N; Guin D; Sood M; Chadda RK; Yadav J; Vohora D; Saso L; Kukreti R
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNFAIP3, a negative regulator of the TLR signaling pathway, is a potential predictive biomarker of response to antidepressant treatment in major depressive disorder.
    Hung YY; Lin CC; Kang HY; Huang TL
    Brain Behav Immun; 2017 Jan; 59():265-272. PubMed ID: 27640899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide microarray analysis of gene expression profiling in major depression and antidepressant therapy.
    Lin E; Tsai SJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():334-40. PubMed ID: 25708651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-based gene expression signatures of medication-free outpatients with major depressive disorder: integrative genome-wide and candidate gene analyses.
    Hori H; Sasayama D; Teraishi T; Yamamoto N; Nakamura S; Ota M; Hattori K; Kim Y; Higuchi T; Kunugi H
    Sci Rep; 2016 Jan; 6():18776. PubMed ID: 26728011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in leukocyte transcriptional control pathway activity associated with major depressive disorder and antidepressant treatment.
    Mellon SH; Wolkowitz OM; Schonemann MD; Epel ES; Rosser R; Burke HB; Mahan L; Reus VI; Stamatiou D; Liew CC; Cole SW
    Transl Psychiatry; 2016 May; 6(5):e821. PubMed ID: 27219347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological profiling of prospective antidepressant response in major depressive disorder: Associations with (neuro)inflammation, fatty acid metabolism, and amygdala-reactivity.
    Mocking RJT; Nap TS; Westerink AM; Assies J; Vaz FM; Koeter MWJ; Ruhé HG; Schene AH
    Psychoneuroendocrinology; 2017 May; 79():84-92. PubMed ID: 28262603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptomic signaling pathways involved in a naturalistic model of inflammation-related depression and its remission.
    Moisan MP; Foury A; Dexpert S; Cole SW; Beau C; Forestier D; Ledaguenel P; Magne E; Capuron L
    Transl Psychiatry; 2021 Apr; 11(1):203. PubMed ID: 33824279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment.
    Liou YJ; Chen TJ; Tsai SJ; Yu YW; Cheng CY; Hong CJ
    Pharmacogenet Genomics; 2009 Oct; 19(10):735-41. PubMed ID: 19741570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptomic analyses of humans and mice provide insights into depression.
    Li HJ; Su X; Zhang LW; Zhang CY; Wang L; Li WQ; Yang YF; Lv LX; Li M; Xiao X
    Zool Res; 2020 Nov; 41(6):632-643. PubMed ID: 32987454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polygenic risk scores for major depressive disorder and neuroticism as predictors of antidepressant response: Meta-analysis of three treatment cohorts.
    Ward J; Graham N; Strawbridge RJ; Ferguson A; Jenkins G; Chen W; Hodgson K; Frye M; Weinshilboum R; Uher R; Lewis CM; Biernacka J; Smith DJ
    PLoS One; 2018; 13(9):e0203896. PubMed ID: 30240446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association analysis for corticotropin releasing hormone polymorphisms with the risk of major depressive disorder and the response to antidepressants.
    Chang HS; Won E; Lee HY; Ham BJ; Lee MS
    Behav Brain Res; 2015 Oct; 292():116-24. PubMed ID: 26055202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tryptophan hydroxylase 2 gene is associated with major depression and antidepressant treatment response.
    Tsai SJ; Hong CJ; Liou YJ; Yu YW; Chen TJ; Hou SJ; Yen FC
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):637-41. PubMed ID: 19272410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response.
    Wong ML; Dong C; Maestre-Mesa J; Licinio J
    Mol Psychiatry; 2008 Aug; 13(8):800-12. PubMed ID: 18504423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of mitophagy-related biomarkers and immune infiltration in major depressive disorder.
    Zhang J; Xie S; Xiao R; Yang D; Zhan Z; Li Y
    BMC Genomics; 2023 Apr; 24(1):216. PubMed ID: 37098514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.